Realize the advance in HCV treatment, but remain cautious

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1457-1460

  Asselah, Tarik ^a,b  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Boceprevir; IL28B; Interferon lambda; Pegylated interferon; Polymerase inhibitors; Protease inhibitors; Ribavirin; Telaprevir

Indexed keywords

BOCEPREVIR; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; RIBAVIRIN; TELAPREVIR; VIRUS RNA;

ANEMIA; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FATIGUE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; GENOTYPE; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSOMNIA; NAUSEA; NONHUMAN; NOTE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RETREATMENT; SUSTAINED VIROLOGIC RESPONSE; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 81355161312     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.07.020     Document Type: Note

References (9)

1. T. Asselah, and P. Marcellin New direct-acting antivirals' combination for the treatment of chronic hepatitis C Liver Int 31 2011 68 77
2. T. Asselah A sprint to increase response to HCV treatment: expectancies but caution J Hepatol 55 2011 1154 1158
3. F. Poordad, J. McCone Jr. , and B.R. Bacon Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 2011 1195 1206
4. B.R. Bacon, S.C. Gordon, and E. Lawitz Boceprevir for previously treated chronic HCV genotype 1 infection N Engl J Med 364 2011 1207 1217
5. I.M. Jacobson, J.G. McHutchison, and G. Dusheiko Telaprevir for previously untreated chronic hepatitis C virus infection N Engl J Med 364 2011 2405 2416
6. K.E. Sherman, S.L. Flamm, and N.H. Afdhal Telaprevir in Combination with Peginterferon Alfa2a and Ribavirin for 24 or 48 weeks in Treatment-Naïve Genotype 1 HCV Patients who Achieved an Extended Rapid Viral Response Hepatology 52 2010 LB 2 [AASLD, abstract]
7. S. Zeuzem, P. Andreone, and S. Pol Telaprevir for retreatment of HCV infection N Engl J Med 364 2011 2417 2428
8. P. Marcellin, X. Forns, and T. Goeser Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C Gastroenterology 140 2011 459 468
9. T. Asselah, I. Biche, A. Sabbagh, P. Bedossa, R. Moreau, and D. Valla Gene expression and hepatitis C virus infection Gut 58 2009 846 858